Property:RefUnit
From GxPlex
Unit number this reference belongs to.
U
USA FDA Guidance for Industry - Oversight of Clinical Investigations — A Risk-Based Approach to Monitoring Aug-2013 IV A. +
4.3.3 +
E
EU GUIDANCE ON THE MANAGEMENT OF CLINICAL TRIALS DURING THE COVID-19 (CORONAVIRUS) PANDEMIC v5 10-Feb-2022 11 d) +
4.3.4 +
EU GUIDANCE ON THE MANAGEMENT OF CLINICAL TRIALS DURING THE COVID-19 (CORONAVIRUS) PANDEMIC v5 10-Feb-2022 Annex 1 +
4.3.4 +
D
4.3.4 +
A
F
4.3.4 +
G
GBR Guidance Access to Electronic Health Records by Sponsor representatives in clinical trials 44447 - +
4.3.4 +
GBR Guidance Access to Electronic Health Records by Sponsor representatives in clinical trials 44447 System Security +
4.3.4 +
U
USA FDA Guidance for Industry - Conduct of Clinical Trials of Medical Products During the COVID-19 Public Health Emergency Mar-2020 Q15 +
4.3.4 +
W
I
W
4.4.0 +
WHO WHO - Guidance for best practices for clinical trials 2024 1.1 - Platform, basket and umbrella trials +
4.4.0 +
I
E
